Hofseth BioCare ASA: Mandatory Notification of Trade

Reference is made to the stock exchange announcement by Hofseth Biocare ASA ("HBC" or the "Company") on 27 October 2025 regarding completion of a private placement (the "Private Placement") of new shares in the Company.

In the Private Placement, Hofseth International AS was allocated 28,666,666 new shares at the subscription price of NOK 1.80.

Please refer to the attached notification form for further information.

This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19.

For further information, please contact:

Jon Olav Ødegård, CEO at HBC
Phone: +47 936 32 966
E-mail: [email protected]

Attachment

• PDMR notification form Hofseth International AS

You May Also Be Interested In

• Joveo to Unveil the First Agentic Recruiting Platform to Connect the Full Hiring Funnel at RecFest 2026
• Results of additional issuance - RIKB 38 0215 - RIKS 50 0915
• VINCI: Disclosure of transactions on shares from September 14, 2026, to September 18, 2026